Literature DB >> 626223

Prediction of individual dosage of nortriptyline.

T B Cooper, G M Simpson.   

Abstract

The authors describe a technique that enables a physician to determine individual patient dosage requirements for nortriptyline from a single 24-hour blood sample. Because the technique reveals immediately those patients at the extremes of dosage ranges, toxicity and the need for time-consuming titration of the dosage regimen can be avoided.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626223     DOI: 10.1176/ajp.135.3.333

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  15 in total

1.  Poor correlation between single-dose data and steady-state kinetics for phenobarbitone, primidone, carbamazepine and sodium valproate in children during monotherapy. Possible reasons for the lack of correlation.

Authors:  J A Armijo; J L Herranz; R Arteaga; R Valiente
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

2.  Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

Authors:  Charles H Kellner; Rebecca G Knapp; Georgios Petrides; Teresa A Rummans; Mustafa M Husain; Keith Rasmussen; Martina Mueller; Hilary J Bernstein; Kevin O'Connor; Glenn Smith; Melanie Biggs; Samuel H Bailine; Chitra Malur; Eunsil Yim; Shawn McClintock; Shirlene Sampson; Max Fink
Journal:  Arch Gen Psychiatry       Date:  2006-12

3.  Prediction of steady-state nortriptyline plasma levels by the repeated one-point method.

Authors:  W K Fant; W A Ritschel; S K Alwis; S Roe; J Ehret
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

4.  Two prospective dosing methods for nortriptyline.

Authors:  P J Perry; J L Browne; B Alexander; M T Tsuang; A D Sherman; F J Dunner
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

5.  Single-dose single-point method in amitriptyline therapy.

Authors:  S Madakasira; P G Khazanie; T L Sato
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Prediction of maintenance dose required to attain a desired drug concentration at steady-state from a single determination of concentration after an initial dose.

Authors:  J T Slattery; M Gibaldi; J R Koup
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

7.  A simulation study of parameter estimation in the one and two compartment models.

Authors:  P M Laskarzewski; D L Weiner; L Ott
Journal:  J Pharmacokinet Biopharm       Date:  1982-06

8.  Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.

Authors:  A Shvartsburd; V Nwokeafor; R C Smith
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  The pharmacokinetics of nortriptyline in patients with chronic renal failure.

Authors:  S Dawlilng; K Lynn; R Rosser; R Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

10.  Clinical pharmacokinetics of dothiepin. Single-dose kinetics in patients and prediction of steady-state concentrations.

Authors:  K P Maguire; T R Norman; I McIntyre; G D Burrows
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.